Annexin Pharmaceuticals (Sweden) Probability of Future Stock Price Finishing Over 0.3
| ANNX Stock | SEK 0.30 0.02 7.14% |
Annexin |
Annexin Pharmaceuticals Target Price Odds to finish over 0.3
The tendency of Annexin Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.30 | 90 days | 0.30 | about 1.15 |
Based on a normal probability distribution, the odds of Annexin Pharmaceuticals to move above the current price in 90 days from now is about 1.15 (This Annexin Pharmaceuticals AB probability density function shows the probability of Annexin Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon the stock has the beta coefficient of 1.58 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Annexin Pharmaceuticals will likely underperform. Additionally Annexin Pharmaceuticals AB has an alpha of 0.1301, implying that it can generate a 0.13 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Annexin Pharmaceuticals Price Density |
| Price |
Predictive Modules for Annexin Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Annexin Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Annexin Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Annexin Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Annexin Pharmaceuticals is not an exception. The market had few large corrections towards the Annexin Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Annexin Pharmaceuticals AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Annexin Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 0.13 | |
β | Beta against NYSE Composite | 1.58 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | 0.03 |
Annexin Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Annexin Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Annexin Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Annexin Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Annexin Pharmaceuticals had very high historical volatility over the last 90 days | |
| Annexin Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (52.14 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Annexin Pharmaceuticals AB has accumulated about 22.77 M in cash with (45.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 45.0% of the company shares are held by company insiders |
Annexin Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Annexin Stock often depends not only on the future outlook of the current and potential Annexin Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Annexin Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 92.3 M | |
| Cash And Short Term Investments | 49.5 M |
Annexin Pharmaceuticals Technical Analysis
Annexin Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Annexin Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Annexin Pharmaceuticals AB. In general, you should focus on analyzing Annexin Stock price patterns and their correlations with different microeconomic environments and drivers.
Annexin Pharmaceuticals Predictive Forecast Models
Annexin Pharmaceuticals' time-series forecasting models is one of many Annexin Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Annexin Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Annexin Pharmaceuticals
Checking the ongoing alerts about Annexin Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Annexin Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Annexin Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Annexin Pharmaceuticals had very high historical volatility over the last 90 days | |
| Annexin Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (52.14 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Annexin Pharmaceuticals AB has accumulated about 22.77 M in cash with (45.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 45.0% of the company shares are held by company insiders |
Check out Annexin Pharmaceuticals Backtesting, Annexin Pharmaceuticals Valuation, Annexin Pharmaceuticals Correlation, Annexin Pharmaceuticals Hype Analysis, Annexin Pharmaceuticals Volatility, Annexin Pharmaceuticals History as well as Annexin Pharmaceuticals Performance. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Annexin Stock analysis
When running Annexin Pharmaceuticals' price analysis, check to measure Annexin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexin Pharmaceuticals is operating at the current time. Most of Annexin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Annexin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Annexin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |